Board of Directors 
 |
Henry Hyde-Thomson Chairman |
Founder and Chairman of Anglo Scientific, 21Net and Phasor Solutions. Co-founder and Director of L3 Technology, a medical diagnostics company. Previously Founder and Chairman of Speech Machines, acquired by Philips in 2001. |
 |
Director |
20 years of international healthcare experience in Corporate & Business Development, Mergers & Acquisitions and Strategic Planning. He has held senior management positions at Serono, Novartis Consumer Health; Baxter, Roche, Andersen Consulting and Rhone-Poulenc. BA majoring in Economics & Commerce and a MBA from ESSEC.Currently CEO and director at Horizon Science Pvt Ltd. |
 |
Director |
Anglo Scientific Principal and Co-founder/Director of Solus Scientific. He previously worked in Technology Mergers & Acquisitions with UBS Investment Bank in San Francisco and has an MBA from London Business School. |
 |
CEO |
Previously CEO and Co-founder of RepRegen (2006-2010), director of eight and founder of two life science companies. Former Entrepreneur-in-Residence at Imperial Innovations, former VC at MVM, Dresdner Kleinwort Benson and HBM Partners. Biotech and Pharmaceuticals correspondent for Financial Times. |
 |
CSO |
Professor of Gastroenterology at Salford Royal Hospital NHS Trust. Previously Fellow at the Sobell Department of Neurophysiology, UCL. Fellow of the Royal College of Physicians. Founder and President of the UK Swallowing Research Group, Board Member of the European Globus and Dysphagia Group, Committee Member of British Society of Gastroenterology (Neurogastroenterology and Motility Section) and a Member of the American Gastroenterology Association. |
 |
COO |
Held senior roles at MIMIT and UMIP (University of Manchester medical device development and intellectual property units) and Tepnel Life Sciences, and was responsible for the successful development of many medical devices and technology based products. Board representative for Iduron Ltd and Myconostica Ltd. |
